| 21-May-13 10:00AM | Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) at TheStreet |
| 20-May-13 03:15PM | A New Drug Sales Model at Motley Fool |
| 02:27PM | Ireland Welcomes Watson Pharmaceuticals, an American Success at TheStreet |
| 11:54AM | Is There a Bubble Brewing? at Motley Fool |
| 11:30AM | Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill at Seeking Alpha |
| 10:07AM | Israel seeks to rein in company tax breaks at Reuters |
| 07:46AM | A Broad Look At Teva's Pipeline at Seeking Alpha |
| 19-May-13 08:32PM | SmithOnStocks Opines On Stocks: May 19th Edition at Seeking Alpha |
| 02:00PM | Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started at Motley Fool |
| 12:05PM | Statin Users May Have a Reason to Rejoice After This Data at Motley Fool |
| 17-May-13 11:50AM | Good News For Health Care Stocks Part 2 at Motley Fool |
| 16-May-13 05:01PM | Billionaire Frost Props Up Prolor Bid With Stock Buys at Bloomberg |
| 02:01PM | Antares: Reiteration Of My Buy Recommendation at Seeking Alpha |
| 01:23PM | Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care Innovation Wall Street Transcript |
| 01:03PM | 4 Stocks Improving Performance Of The Health Care Sector at TheStreet |
| 11:20AM | Following Up an Acquisition With an Even Larger Merger? at Motley Fool |
| 15-May-13 10:45AM | 3 Stocks to Get on Your Watchlist at Motley Fool |
| 10:00AM | 5 Stocks Going Ex-Dividend Tomorrow: LAND, RNDY, TROX, R, TEVA at TheStreet |
| 09:53AM | Teva Stock To Go Ex-dividend Tomorrow (TEVA) at TheStreet |
| 08:29AM | Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? at Seeking Alpha |
| 05:17AM | Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning at Seeking Alpha |
| 14-May-13 05:00PM | Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner at TheStreet |
| 03:59PM | Sanofi Smear Campaign to Limit Plavix Competition YCharts |
| 01:57PM | Reminder - Teva Pharmaceutical Industries (TEVA) Goes Ex-Dividend Soon at Forbes |
| 12:24PM | Blue Ridge Capital betting big on a pharma stock at MarketWatch |
| 10:35AM | Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference Business Wire |
| 10:23AM | Markman Hearing A Likely Clearing Event For Cubist - Decision Any Day at Seeking Alpha |
| 06:35AM | Sanofi Fined $52.8 Million for Denigrating Plavix Copies at Bloomberg |
| 13-May-13 06:27PM | Trius Therapeutics: New, Positive Dimension For Investment Outlook at Seeking Alpha |
| 06:04PM | [$$] Unrestricted Plan B Sales Put on Hold at The Wall Street Journal |
| 04:28PM | Tigershark Management: What's This Hedge Fund Buying? at Seeking Alpha |
| 03:45PM | Teva - Alexza Sign Deal for Adasuve Zacks |
| 02:37PM | [$$] U.S. Seeks Delay in Plan B Ruling at The Wall Street Journal |
| 10:42AM | Teva: An Ideal Long-Term Pharma Stock at Seeking Alpha |
| 07:08AM | Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert at Seeking Alpha |
| 12-May-13 04:10PM | How the Patent Cliff Is Shrinking U.S. Spending at Motley Fool |
| 03:54AM | China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million at Seeking Alpha |
| 10-May-13 05:07PM | Morning-After Pill Judge Wont Delay Ruling for Appeal at Bloomberg |
| 01:48PM | Israel finance minister seeks to curb corporate tax benefits at Reuters |
| 12:19PM | Judge denies FDA bid to stay 'morning-after' pill ruling at Reuters |
| 11:31AM | U.S. judge denies FDA's bid to stay ruling on "morning-after" pill at Reuters |
| 10:22AM | Cramer Says Sell Teva Pharmaceutical, But Buy SunTrust Banks and These 2 Stocks at Wall St. Cheat Sheet |
| 10:00AM | Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) at TheStreet |
| 09-May-13 06:42PM | Lightning Round: SunTrust, Nokia & More at CNBC |
| 06:40PM | [video] Lightning Round at CNBC |
| 04:45PM | Adasuve Deal Is Very Good For Alexza, But What About Teva? at Investopedia |
| 04:35PM | Teva initiated with an Outperform at BMO Capital theflyonthewall.com |
| 11:30AM | Is Motherhood Better or Worse for the Economy? at Motley Fool |
| 10:00AM | X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 16 at Minyanville |
| 07:30AM | Big Drug Companies Are Selling Fewer Pills, But Charging More at Forbes |
| 08-May-13 09:37PM | 3 Healthcare Stock Stories Prescribed For Investors at Wall St. Cheat Sheet |
| 06:41PM | Lightning Round: Hertz, US Airways & More at CNBC |
| 01:52PM | Antares Q1 Results Unimpressive, but Otrexup Could Be Catalyst at Motley Fool |
| 01:30PM | Alexza Pharma jumps on Adasuve licensing deal AP |
| 12:37PM | McDonalds Slides on European Declines, Exxon and Statoil Agree on Julia, and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 11:57AM | InPlay: Teva Pharma: New data presented demonstrates ovulatory effect of Teva Women's Health's investigational 28-day oral contraceptive; ovarian activity was reduced in subjects receiving treatments with modified hormone-free intervals Briefing.com |
| 11:55AM | New Data Presented Demonstrates Ovulatory Effect of Teva Womens Healths Investigational 28-Day Oral Contraceptive Business Wire |
| 11:30AM | Amgen Chased By The Bubble at Investopedia |
| 09:18AM | Teva to market Alexza agitation treatment in the U.S. at Reuters |
| 08:35AM | Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE® in the U.S. PR Newswire |
| 08:30AM | Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S. PR Newswire |
| 08:30AM | Teva and Alexza Announce Tevas License to Market ADASUVE® in the U.S. Business Wire |
| 02:02AM | Teva's CEO Thinks China Is A 'Natural Fit' at Seeking Alpha |
| 07-May-13 05:23PM | [$$] Judge Berates Government on Plan B at The Wall Street Journal |
| 03:32PM | [$$] Judge Berates Government Shift On Plan B at The Wall Street Journal |
| 01:03PM | 5 Stocks Advancing The Drugs Industry at TheStreet |
| 06-May-13 06:40PM | 2 Stocks To Buy, 1 Stock To Avoid, What's Next For The Market at Seeking Alpha |
| 02:45PM | OncoGenex Loss Lower than Expected Zacks |
| 12:20PM | Teva Beats on Earnings, Revenues Zacks |
| 10:45AM | Teva Womens Health to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists Business Wire |
| 10:37AM | 9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April at Seeking Alpha |
| 04-May-13 05:01PM | 4 Winners and 1 Loser from This Weeks Earnings Storm at Wall St. Cheat Sheet |
| 03-May-13 04:13PM | Teva Pharmaceutical (TEVA) Shares Cross Above 200 DMA at Forbes |
| 02:10PM | Teva Still Too Cheap, But Still Too Uncertain at Investopedia |
| 12:02PM | Higher Success Rates than Small-Molecule Drugs for Antibodies: Antibodies Display More Predictable Pharmacology and More Predictable Toxicity Profiles Wall Street Transcript |
| 11:48AM | Don't Worry for a Second About Gilead's Earnings Miss at Motley Fool |
| 07:10AM | The Plan B Absurdity: Emergency Contraception Is Treated Like A Drug That Could Be Abused at Forbes |
| 02-May-13 09:10PM | Teva Pharmaceutical Industries Limited Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet |
| 04:01PM | OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013 CNW Group |
| 04:00PM | OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013 PR Newswire |
| 03:58PM | I Would Buy a Generic Drug ETF, If One Existed at Motley Fool |
| 03:04PM | Teva Pharmaceutical 1Q profit sinks 27 percent AP |
| 01-May-13 06:30AM | OncoGenex Announces Plans for the Initiation of the Rainier Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer PR Newswire |
| 06:30AM | OncoGenex Announces Plans for the Initiation of the Rainier Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer CNW Group |
| 30-Apr-13 09:40PM | [$$] FDA Lowers Age Restriction on Plan B at The Wall Street Journal |
| 08:58PM | [$$] FDA Lowers Age Restriction on Plan B at The Wall Street Journal |
| 08:26PM | [$$] FDA Lowers Age Restriction on Plan B at The Wall Street Journal |
| 07:12PM | [$$] FDA Lowers Age Restriction on Plan B at The Wall Street Journal |
| 06:57PM | [$$] FDA Lowers Age Restriction on Plan B at The Wall Street Journal |
| 06:51PM | Teva confirms over-the-counter availability of Plan B at theflyonthewall.com |
| 06:50PM | InPlay: Teva Pharma confirms FDA approves over-the-counter availability of Plan B One-Step (levonorgestrel) tablet 1.5 mg for consumers 15 and over Briefing.com |
| 06:49PM | FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over Business Wire |
| 06:10PM | FDA Allows 'Morning After Pill' To Be Sold To Some Teenagers Without A Prescription at Forbes |
| 06:10PM | FDA Allows 'Morning After' Pill To Be Sold Over-The-Counter To Girls Fifteen And Up at Forbes |
| 02:20PM | Bayer Aims to Expand HealthCare Portfolio Zacks |
| 01:36PM | Forbes Earnings Preview: Teva Pharmaceutical Industries at Forbes |
| 08:01AM | OncoGenex Announces that the Borealis-2 Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment CNW Group |
| 08:00AM | OncoGenex Announces that the Borealis-2 Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment PR Newswire |
| 29-Apr-13 10:15AM | Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) at TheStreet |
| 08:00AM | Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer Business Wire |
